ADAMA Ltd (000553)
Shenzhen Stock Exchange · China · prices in CNY · close of 21 Oct 2026
Key indicators
| Last close | CNY 5.140 |
|---|---|
| 52-week range | 5.000 – 7.630 |
| Return, 1 month / 3 months | −9.2% / −2.5% |
| Return, 1 year / 3 years | −20.8% / −33.1% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 37.1% |
| Worst drawdown (1 year) | -32.3% |
| Average daily value traded | 43.47M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ADAMA Ltd is an agricultural chemicals company that develops, makes and sells crop protection products, including herbicides, insecticides and fungicides, along with other inputs used by farmers. Its customers are growers and agricultural distributors in markets around the world. The company has roots in Israel and operates internationally, serving arable and specialty crop farming. It focuses on off-patent and differentiated formulations that help farmers manage weeds, insects and plant diseases.
ADAMA Ltd trades under the code 000553 on the Shenzhen Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ADAMA Ltd (000553) trades on the Shenzhen Stock Exchange in China. It last closed at CNY 5.140 on 21 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 1,058 of 2,821 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.8% and over the last three months it fell 2.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shenzhen Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -13.0% | ||
| From 52-week high | -31.5% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.5% | ||
| 6-month return | -18.8% | ||
| 12-month return, skipping the last month | -12.8% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.3% | ||
| Liquidity | 14 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 43.47M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.9% |
|---|---|
| 1 month | −9.2% |
| 3 months | −2.5% |
| 6 months | −18.8% |
| 1 year | −20.8% |
| 3 years | −33.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 5.531 / 5.906 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.144 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jun 2023 | ILS 0.0270 |
| 7 Jun 2022 | ILS 0.0080 |
| 9 Jul 2021 | ILS 0.0160 |
| 30 Jun 2020 | ILS 0.0120 |
| 24 Jul 2019 | ILS 0.0970 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shenzhen Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.